医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2015年
4期
737-739
,共3页
叶酸/治疗应用%精神分裂症/药物疗法%抗精神病药/治疗应用%双盲法
葉痠/治療應用%精神分裂癥/藥物療法%抗精神病藥/治療應用%雙盲法
협산/치료응용%정신분렬증/약물요법%항정신병약/치료응용%쌍맹법
Folic Acid/TU%Schizophrenia/DT%Antipsychotic Agents/TU%Double-Blind Method
【目的】探讨叶酸辅助治疗精神分裂症阴性症状患者的临床疗效及安全性。【方法】采用随机双盲对照法,将106例以阴性症状为主且单一使用哌罗匹隆治疗的精神分裂症患者分为观察组( n =53,给予叶酸)和对照组( n =53,给予安慰剂),治疗周期为12周。分别于治疗前,治疗第4、8、12周末使用阴性症状评定量表(SANS)评定疗效,使用副反应量表(TESS)评定药物不良反应。【结果】两组SANS总分在治疗第4、8、12周末均较治疗前有明显下降,具有统计学意义( P <0.05);与对照组相比,观察组第4、8、12周末SANS总分均低于对照组,且差异具有统计学意义( P <0.05,P <0.01)。治疗第12周末观察组SANS减分率高于对照组,差异具有统计学意义(P <0.05)。两组不良反应发生率无统计学差异(P >0.05)。【结论】叶酸有助于改善精神分裂症患者的阴性症状,且安全性好。
【目的】探討葉痠輔助治療精神分裂癥陰性癥狀患者的臨床療效及安全性。【方法】採用隨機雙盲對照法,將106例以陰性癥狀為主且單一使用哌囉匹隆治療的精神分裂癥患者分為觀察組( n =53,給予葉痠)和對照組( n =53,給予安慰劑),治療週期為12週。分彆于治療前,治療第4、8、12週末使用陰性癥狀評定量錶(SANS)評定療效,使用副反應量錶(TESS)評定藥物不良反應。【結果】兩組SANS總分在治療第4、8、12週末均較治療前有明顯下降,具有統計學意義( P <0.05);與對照組相比,觀察組第4、8、12週末SANS總分均低于對照組,且差異具有統計學意義( P <0.05,P <0.01)。治療第12週末觀察組SANS減分率高于對照組,差異具有統計學意義(P <0.05)。兩組不良反應髮生率無統計學差異(P >0.05)。【結論】葉痠有助于改善精神分裂癥患者的陰性癥狀,且安全性好。
【목적】탐토협산보조치료정신분렬증음성증상환자적림상료효급안전성。【방법】채용수궤쌍맹대조법,장106례이음성증상위주차단일사용고라필륭치료적정신분렬증환자분위관찰조( n =53,급여협산)화대조조( n =53,급여안위제),치료주기위12주。분별우치료전,치료제4、8、12주말사용음성증상평정량표(SANS)평정료효,사용부반응량표(TESS)평정약물불량반응。【결과】량조SANS총분재치료제4、8、12주말균교치료전유명현하강,구유통계학의의( P <0.05);여대조조상비,관찰조제4、8、12주말SANS총분균저우대조조,차차이구유통계학의의( P <0.05,P <0.01)。치료제12주말관찰조SANS감분솔고우대조조,차이구유통계학의의(P <0.05)。량조불량반응발생솔무통계학차이(P >0.05)。【결론】협산유조우개선정신분렬증환자적음성증상,차안전성호。
[Objective] To evaluate the clinical efficacy and safety of folic acid in the treatment of negative symptoms in schizophrenics .[Methods] For this double‐blind controlled trial ,a total of 106 schizophrenics with predominantly negative symptoms on a monotherapy of perospirone hydrochloride were assigned into trial (folic acid ,n =53) and control (placebo ,n =53) groups .During an observation period of 12 weeks ,all par‐ticipants completed the scales of scale for the assessment of negative symptoms (SANS) and treatment emer‐gent symptom scale (TESS) to assess the status of negative symptoms and adverse drug reactions at baseline and at the end of weeks 4 ,8 and 12 of treatment .[Results] Compared with baseline data ,the total SANS scores of both two groups significantly decreased at weeks 4 ,8 and 12 .And the differences had statistical sig‐nificance ( P <0 .05) .The mean total SANS scores of study group were lower than those of control group at weeks 4 ,8 and 12 .And inter‐group differences existed ( P <0 .05 ,P <0 .01) .Furthermore ,study group had a higher declining rate than control group at week 12 .And the changes showed significant inter‐group differences ( P<0 .05) .No significant inter‐group difference existed in the ratio of adverse drug reactions ( P>0 .05) .[Conclusion]Folic acid is both effective and safe for improving negative symptoms in schizophrenics .